Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Associations were confirmed for HLA‐B44 (pooled Odds Ratio 8.15, 95% Confidence Interval 1.61 to 41.29; I 2 = 86%) and vitamin‐D‐receptor polymorphisms FokI, TaqI and BsmI, each conferring a 1.5‐ to 2.1‐fold increased risk.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Is there a role of genetics in acute and chronic urticaria: A systematic review and meta‐analysis

Source: Article title.

Is there a role of genetics in acute and chronic urticaria: A systematic review and meta‐analysis

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Is there a role of genetics in acute and chronic urticaria: A systematic review and meta‐analysis

Systematic review · Clinical and Translational Allergy · 2025

Original publication title

Is there a role of genetics in acute and chronic urticaria: A systematic review and meta‐analysis

George N. Konstantinou; Indrashis Podder; Arunima Dhabal

© 2025 The Author(s). Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

CU displays an autoimmune‐like genetic signature. HLA‐B44 and vitamin D receptor variants are susceptibility markers, and pharmacogenetic signals enable personalised therapy. Longitudinal studies integrating environmental exposures and functional genomics are needed to translate these insights into precision care.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To systematically review and meta‐analyse genetic and epigenetic factors that influence susceptibility and treatment response in acute and CU.

Source: Objective

Abstract: What methods does the paper describe?

Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, PubMed, Scopus and Web of Science were searched from inception to 31 July 2024. Original human studies reporting genetic or epigenetic associations with any urticaria subtype were eligible. Random‐effects meta‐analyses were undertaken when at least three comparable datasets were available.

Source: Methods

Abstract: Results

Sixty‐one studies met the inclusion criteria. Associations were confirmed for HLA‐B44 (pooled Odds Ratio 8.15, 95% Confidence Interval 1.61 to 41.29; I 2 = 86%) and vitamin‐D‐receptor polymorphisms FokI, TaqI and BsmI, each conferring a 1.5‐ to 2.1‐fold increased risk. Variants in CRTH2, FcεR1α and C‐reactive protein predicted antihistamine response, while FCER1G, IL‐6, prostaglandin‐endoperoxide synthase 2, CCL2 and TNF‐pathway genes were over‐expressed in lesional tissue, supporting an immune‐mediated pathogenesis. Evidence for non‐CSU subtypes, acute urticaria, epigenetic modifications and gene: environment interactions was limited.

Source: Results

Abstract: Conclusions

CU displays an autoimmune‐like genetic signature. HLA‐B44 and vitamin D receptor variants are susceptibility markers, and pharmacogenetic signals enable personalised therapy. Longitudinal studies integrating environmental exposures and functional genomics are needed to translate these insights into precision care.

Source: Conclusions
Authors’ abstract

Abstract

Background

Chronic urticaria (CU) is a heterogeneous skin disorder whose genetic drivers are incompletely defined.

Objective

To systematically review and meta‐analyse genetic and epigenetic factors that influence susceptibility and treatment response in acute and CU.

Methods

Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, PubMed, Scopus and Web of Science were searched from inception to 31 July 2024. Original human studies reporting genetic or epigenetic associations with any urticaria subtype were eligible. Random‐effects meta‐analyses were undertaken when at least three comparable datasets were available.

Results

Sixty‐one studies met the inclusion criteria. Associations were confirmed for HLA‐B44 (pooled Odds Ratio 8.15, 95% Confidence Interval 1.61 to 41.29; I 2 = 86%) and vitamin‐D‐receptor polymorphisms FokI, TaqI and BsmI, each conferring a 1.5‐ to 2.1‐fold increased risk. Variants in CRTH2, FcεR1α and C‐reactive protein predicted antihistamine response, while FCER1G, IL‐6, prostaglandin‐endoperoxide synthase 2, CCL2 and TNF‐pathway genes were over‐expressed in lesional tissue, supporting an immune‐mediated pathogenesis. Evidence for non‐CSU subtypes, acute urticaria, epigenetic modifications and gene: environment interactions was limited.

Conclusions

CU displays an autoimmune‐like genetic signature. HLA‐B44 and vitamin D receptor variants are susceptibility markers, and pharmacogenetic signals enable personalised therapy. Longitudinal studies integrating environmental exposures and functional genomics are needed to translate these insights into precision care.

Publication and source details

Original title: Is there a role of genetics in acute and chronic urticaria: A systematic review and meta‐analysis

George N. Konstantinou; Indrashis Podder; Arunima Dhabal

Clinical and Translational Allergy · 2025

* Correspondence
George N. Konstantinou, Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Dorilaiou 10, Kalamaria 55 133, Thessaloniki, Greece.
Email: gnkonstantinou@gmail.com
© 2025 The Author(s). Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:29:36.423626+00:00

DOI: 10.1002/clt2.70072 · PMC12240874